Comparison of a treatment regimen based on serum procalcitonin levels versus a standard treatment regimen in patients hospitalized for exacerbation of chronic obstructive pulmonary disease - ND

Machine translation Machine translation
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2007
INTERVENTION: Pharmaceutical Form: Powder for oral solution Concentration unit: g gram(s) Concentration type: equal Concentration number: 1- Pharmaceutical Form: Tablet Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 250- CONDITION: Infectious exacerbation of COPD. ; MedDRA version: 6.1 Level: PT Classification code 10053582 PRIMARY OUTCOME: Main Objective: Compare two antibiotic therapy regimens for the treatment of COPD patients hospitalized for infectious exacerbation of disease Primary end point(s): Number of exacerbations within 6 months of study entry Secondary Objective: Estimate direct and indirect costs of hospitalized patients with COPD INCLUSION CRITERIA: Patients hospitalized for infectious exacerbation of COPD Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 5932f5e0411150afd71ea278a3aaf144038bbe60
First added on: Aug 21, 2024
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: Italiano

If you prefer to see the machine translation we assume you accept our terms of use